Denmark· DK-28100009555
Kemadrin
A procyclidine product containing procyclidinhydrochlorid, registered in Denmark by Aspen Pharma Trading Ltd.. The same ATC class is registered in 8 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Procyclidine is registered in 8 of 19 countries.
Countries holding a registration under ATC N04AA04 (procyclidine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 4 of them publish a price we can compare per daily dose
Procyclidine · ATC N04AA04
8 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Norwayprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of procyclidine costs, country by country.
Normalised to the WHO defined daily dose (25 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Procyclidine · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.57
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- PROCYCLIDINHYDROCHLORID
- Manufacturer
- Aspen Pharma Trading Ltd.
- Country
- Denmark (DK)
- ATC code
- N04AA04
- ATC class
- Procyclidine
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28100009555
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for procyclidine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Procyclidine · interactions on record
89 records
- 3 severe
- 85 moderate
- 1 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- DicycloverineA03AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N04AA04
Procyclidine, as other registers publish it.
- United KingdomArpicolin 2.5mg/5ml oral solutionRosemont Pharmaceuticals Ltd
- United KingdomArpicolin 5mg/5ml oral solutionRosemont Pharmaceuticals Ltd
- NorwayKemadrinGlaxoSmithKline
- FinlandKemadrinThe Wellcome Foundation Limited
- SwitzerlandKemadrin
- United KingdomKemadrin 10mg/2ml solution for injection ampoulesAuden McKenzie (Pharma Division) Ltd
- BelgiumKemadrin 5 mgAspen Pharma Trading
- IrelandKemadrin 5 mg tabletsPCO Manufacturing Ltd.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08fe238e-f231-4ac4-b05a-b2d9ce428565 GET /v1/drugs/08fe238e-f231-4ac4-b05a-b2d9ce428565?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter",
"source": "dkma",
"strength": "5 mg",
"auth_role": "DKMA",
"dk_drugid": "28100009555",
"substance": "PROCYCLIDINHYDROCHLORID",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "20193"
}See everything about procyclidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.